Skin cream trial to prevent relapses in very dry eczema skin
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is ages 6 months to 15 years
- Your child has eczema (atopic dermatitis) with about 1 flare-up per month in the last 4 months
- At the start visit, the eczema score is in the moderate range (EASI 7.1 to 21)
- On the start visit, there is a current eczema spot that the dermatologist will treat with topical steroid or tacrolimus/pimecrolimus
- Your child must avoid using other skin moisturizers on the study area besides the study cream or its match (placebo)
- Your child cannot have other skin conditions in the treated area like acne or psoriasis, and cannot be allergic to ingredients in the study cream
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new dermocosmetic cream for children with eczema. It looks at how well the cream works and how gentle it is on the skin, after the child uses a prescribed steroid cream to calm a flare-up.
This study tests a new moisturizing product (RV4421B) for people with mild to moderate atopic dermatitis (eczema). Participants will use the product along with their usual steroid cream for 12 weeks to see how well it works and if it’s safe for different ages, from babies to adults.
This study tests an oral medication (EC-18) for moderate to severe atopic dermatitis (eczema) to see if it can improve symptoms like itching and skin rash. It may be an option for people whose eczema is not controlled by topical treatments.
This trial tests a study drug (PF-08049820) for people with moderate to severe eczema who haven't found a suitable prescription treatment. It aims to see if the drug can improve skin symptoms and itching.
This study tests an investigational cream for moderate to severe eczema. It helps see if the cream reduces symptoms like itching and skin inflammation.
This study tests two new study medicines (PF-07275315 and PF-07264660) for people with moderate to severe eczema that hasn't responded well to other treatments, including biologics. The goal is to see if these medicines can help reduce itching and clear the skin.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.